(Date:11/5/2009)..., The National Association of Biology Teachers (N...r of biological sciences at Naugatuck Valley Commu...h the 2009 Evolution Education Award during the NA...e held 11-14 November 2009 in Denver, Colorado. ,...the American Institute of Biological Sciences,(AI...
(Date:11/4/2009)..., LEADS: (top news in natural science) , U...d States uses less water today than it did 35 year...eclines in water use are partly attributable to al... efficient irrigation systems. According to the la...er used in the United States goes to cooling therm...
(Date:11/4/2009)..., The Singapore laboratory that deciphered the DN...ish) and elephant shark, has joined The Genome 10K...luable repository of DNA sequences on 10,000 speci...n a scale that currently can not be achieved. , ... in a paper published in the Nov. 5, 2009 issue of...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2Actelion Launches Increased Strength Formulation of Ventavis 28Iloprost 29 for Pulmonary Arterial Hypertension in the United States 13785 1Actelion Launches Increased Strength Formulation of Ventavis 28Iloprost 29 for Pulmonary Arterial Hypertension in the United States 13785 2Actelion Launches Increased Strength Formulation of Ventavis 28Iloprost 29 for Pulmonary Arterial Hypertension in the United States 13785 3Government Best Source for U S Hospital Data Study Finds 55940 1Government Best Source for U S Hospital Data Study Finds 55940 2Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 1Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 2Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 3(Date:11/5/2009)....Y., Nov. 5 BioSpecifics...eutical company developing first-in-class collagen...results for the third quarter ended September 30, ...tember of this year, the FDA,s Arthritis Advisory ...-0, the approval of XIAFLEX(TM) for the treatment ...
(Date:11/5/2009)...as, Nov. 5 SpineSmith Partners has...o co-develop a unique scaffold that mimics the str...uation of several commercial products by SpineSmit...ny believes the GenOsteo scaffold represents a sig...unique and ideal environment for the delivery of a...
(Date:11/4/2009)... This webinar, which will be presented on ...n continuous flow chemistry processing, will deal ...ne using various meso and micro scale flow chemist...blications has been recognized with several presti...he 2009 Tetrahedron Prize. , ...
(Date:11/4/2009)... Calif., Nov. 4 Onyx Pha...d that it will present at the Credit Suisse 18th A... 11, at 9:30 a.m. Mountain Time (8:30 a.m. Pacific...ast of the presentation on our website at: http:...,, It is recommended that listeners log on 15 m...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3... in Women,s Health (NPWH) Encourages Women to Get...SHINGTON, Feb. 20 Despite growing awareness of HP...vical cancer, a new survey,released by the Nationa...alth (NPWH) found that many women remain in the da...pite the fact that there is now a vaccine that,can...
...hn,s Disease, Pouchitis and ...era Therapeutics, a,biopharmaceutical company focu...ation of proprietary compounds to treat a broad ra...nounced the completion of a,$35.5 million Series C...estors., New investor Montagu Newhall Associates ...
...627 Million; GAAP EPS $0.34; ...Net Revenue Reaches $2.50 Billion; 2007 GAAP EPS ... CORONA, Calif., Feb. 20 Watson,Pharmaceuticals,...tical,company, today reported fourth quarter and f...r ended December 31, 2007 and provided an outlook ...
Other Biology Technology:Survey Shows Most Women Can't Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 2Survey Shows Most Women Can't Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3Survey Shows Most Women Can't Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 4Ocera Therapeutics Closes $35.5 Million Series C Financing 2Ocera Therapeutics Closes $35.5 Million Series C Financing 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 4Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 5Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 6Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 7Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 8Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 9Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 10Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 11Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 12Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 13Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 14Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 15Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 16Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 17Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 18Streptavidin, PE conjugated/tagged from Invitrogen
GIBCO RPMI Medium 1640; powder from Invitrogen
...5 ml Dynabeads Tosylactivated (4.5 m). Hydrophobi...tive groups. For coupling of antibodies for cell a... on initial coupling with covalent binding of prim...)) occurringovernight. Coupling reactions can be p...
Mouse Anti-Mouse BKBeta2 potassium channel Monoclonal Antibody, Unconjugated, Clone N53/32 from UC Davis/NINDS/NIMH NeuroMab Facility
Biology Products: